risk of death, 81.9% lower, RR 0.18, p = 0.01, treatment 2 of 157 (1.3%), control 11 of 156 (7.1%), NNT 17, all cases.
|
risk of death, 67.1% lower, RR 0.33, p = 0.49, treatment 0 of 107 (0.0%), control 1 of 103 (1.0%), NNT 103, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), moderate cases.
|
risk of death, 78.8% lower, RR 0.21, p = 0.03, treatment 2 of 50 (4.0%), control 10 of 53 (18.9%), NNT 6.7, severe cases.
|
risk of no recovery, 83.6% lower, HR 0.16, p < 0.001, treatment 107, control 103, moderate cases.
|
risk of no recovery, 75.2% lower, HR 0.25, p < 0.001, treatment 50, control 53, severe cases.
|
risk of no viral clearance, 81.9% lower, HR 0.18, p < 0.001, treatment 107, control 103, moderate cases.
|
risk of no viral clearance, 76.9% lower, HR 0.23, p < 0.001, treatment 50, control 53, severe cases.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |